Harlan Robins spent years as the co-founder and chief scientific officer of Adaptive Biotechnologies, helping build massive datasets to decode the human immune system. Read More
A biomanufacturing facility in Everett that Pfizer decided to shut down before it opened is getting a new lease on life, with a new owner and a 21-year lease to an unnamed global biopharmaceutical company. Read More
Developing the next generation of RNA- and DNA-based medicines requires a level of precision that many existing research tools can’t provide. Vancouver, B.C.-based startup ScopeSys aims to change that. Read More
Seattle startup Iridius, founded by former Microsoft and AWS leaders, is building software that embeds regulatory compliance into AI systems as they run. Accenture is both an investor and a strategic partner. Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering.… Read More
SAN FRANCISCO — Can artificial intelligence help battle malaria and other infectious diseases? Intellectual Ventures CEO Nathan Myhrvold says it’s time… Read More
The U.S. healthcare system faces a myriad of challenges today, including uncertainty over federal regulation and shifting payer systems. You… Read More
Life Science Washington, the trade association formerly known as the Washington Biotechnology & Biomedical Association, has named Leslie M. Alexandre as… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
